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Abstract 
The National Science Foundation (NSF) estimates that nanotechnology will become a 
trillion-dollar industry by 2015 and that 800,000 workers will be needed in this field in the 
United States.  Nanobiotechnology ― the interface of nanotechnology and the life sciences ― is 
one of the most active and promising application frontiers in nanotechnology.  To assess the 
productivity of university basic and applied research and education in this field, I construct a 
structural model composed of a system of three equations which respectively represent the 
productions of a university’s scientific publications, patents, and graduate training outputs.  The 
model is estimated using a unique data set on thirty universities that participated in 
nanobiotechnology during the 1990-2005 period.  Ten of them are land-grant universities, ten are 
non-land-grant pubic universities, and ten are private universities.   
Universities indeed serve as a principal seedbed for future development of the cutting-
edge nanobiotechnology.  NSF investment in nanobiotechnology significantly affects the 
university’s basic science research and graduate education.  The university’s research 
expenditures in life sciences, engineering, and physical sciences contribute to its 
nanobiotechnology fields.  Importantly, there is no evidence that research and graduate training 
compete strongly with one another.  Rather, basic science research and graduate education serve 
as strong complements to one another, basic science and applied research, and applied research 
and graduate education both serve as weak complements for one another.  Ceteris paribus, non-
land-grant public universities and universities without medical school or hospital are more 
efficient in patent production.  Presence of a nanotechnology research center on campus 
enhances the university’s basic science research and a formal nanotechnology education program 
promotes the university’s graduate education.   2 
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Overview of Nanotechnology and Nanobiotech 
Nanoscale science and technology (hereinafter referred to as nanotechnology) deals with 
the observation, measurement, and manipulation of matter at the length scale of approximately  
1-100 nanometers.  The goal of nanotechnology is to create and subsequently utilize functional 
nano-sized materials that have properties entirely different from their bulk counterparts and thus 
provide unprecedented capabilities in basic scientific research and novel device and system 
design.  Nanobiotech ― one of the most active and promising application frontiers in 
nanotechnology ― lies at the interface of nanotechnology and the life sciences. Whereas 
nanotechnology offers new concepts, tools, and materials to characterize and transform 
biosystems, life science presents unique examples of natural functional nanostructures including 
DNA and protein to guide the synthesis of new nanomaterials and the assembly of new 
nanodevices (Whitesides). 
Today, it is widely believed that nanotechnology has the long-term potential to change 
our economy as profoundly as did the transistor and the internet (Roco and Bainbridge).  The 
National Science Foundation (NSF) estimates that nanotechnology will become a trillion-dollar 
industry by 2015 and that 800,000 workers will be needed in this field in the United States.  
Recognizing nanotechnology’s promise as one of the driving forces of technical innovation and 
economic growth, the U.S. government launched the National Nanotechnology Initiative (NNI) 
in 2000 to coordinate multiple federal agencies’ nanoscale research and development programs.  
Indeed, U.S. federal investment in nanotechnology has increased more than eightfold in the past 
seven years, from $116 million in 1997 to $961 million in 2004.  These investments support not 3 
 
only individual research projects but also multidisciplinary research centers and education 
programs.  In particular, the proportion of these investments devoted to nanobiotech has risen 
from around 10 to 15 percent between 2000 and 2003 to 25 percent in 2004.  
While commercial products from nanotechnology are already reaching the market, most 
applications are still at the concept level, requiring much more basic research before they can be 
incorporated into viable products.  Until that takes place, the private sector will not invest in this 
risky and costly enterprise.  Consequently, public funding for university basic research and early-
stage development in nanotechnology is critical for creating the scientific base and for preparing 
a new generation of qualified workers for future nanotechnological development. 
Besides federal funding, state and local government funding and policies play an 
increasingly significant role in university research/education performance in nanotechnology.  
Having identified nanotechnology as the next growth industry, nearly every economic center has 
developed an interest in it and some of them have made large commitments toward 
nanotechnology research.  Take Missouri as an example.  Although it ranks low nationwide in 
economic development from nanotechnology (Lux Research Inc.), it recently began focusing on 
nanobiotech in order to leverage its unique strength in traditional life science.  Nanobiotech also 
has become one of the top research thrusts at the University of Missouri.  The state-of-art Life 
Sciences Center at the University of Missouri provides a common platform for the incorporation 
of nanotechnology into biotechnology and the life sciences.  Multidisciplinary research and 
education efforts such as the Nanotechnology Initiative Program are well underway and the 
establishment of a campus-wide or University of Missouri System-wide nanotechnology center 
is under discussion.   
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Economics Literature on University Research and Education 
Recognizing the private sector’s heavy reliance on basic science, economists have long 
sought to measure the economic contribution of university research.  For example, some 
economists have explored the relationship between university research expenditures and either 
commercial product output or multifactor productivity growth (Adams).  Some have 
concentrated on university research expenditures as an input to firms’ innovation rates (Jaffe), 
while others have investigated the geographical proximity of private firms to leading university 
scientists (Zucker, Darby, and Brewer; Darby and Zucker). 
Another line of economic study of university research focuses on the input-output 
relationship in the research process itself, employing the knowledge production function 
framework pioneered by Zvi Griliches in the late 1960s.  Knowledge inputs in such a framework, 
chiefly intellectual human capital and economic resources, serve to produce knowledge outputs.  
As universities traditionally have been dedicated to free dissemination of research results, 
scientific publication has most often been used as the output indicator.  For example, Adams and 
Griliches examined the research performance of U.S. universities in eight broad scientific fields.  
Elasticities of publication with respect to research expenditure were below unity in all fields, 
implying decreasing returns.  More recently, Xia and Buccola studied the impact of universities’ 
life science budgets on the quantity of their publications cited in agricultural biotechnology 
patents and on their bioscience graduate training.  Publication numbers and graduate training 
showed, respectively, increasing and decreasing returns to budget scale, and a graduate 
program’s quality ranking had a positive impact on research and training. 
With the recent trend toward privatization of research findings, economists have begun 
analyzing university production of proprietary knowledge outputs, often measured through 5 
 
patents.  For example, Foltz, Kim, and Barham examined the production of agricultural 
biotechnology patents in 100 U.S. universities, concluding that the Land Grant infrastructure and 
previous patent success significantly affect a university’s patent output.  These studies focus on 
the production of only one research output, either publication rate or patent count.  In fact, 
university research tends to produce both outputs, and generating one may well affect the other 
on account of resource limitations and the strong connection between science and technology.  
Another complicating factor is the graduate education of the science and engineering workforce, 
which is closely related to universities’ research activities but has not been explicitly modeled in 
most economic studies. 
 
Econometric Model 
  To comprehensively assess the productivity of university basic and applied research and 
education in nanobiotechnology, I construct a structural model composed of a system of three 
equations which respectively represent the productions of a university’s scientific publications, 
patents, and graduate training outputs.  The model is outlined below.  All variables refer to 
nanobiotech unless otherwise indicated.  In a given year at a given university, let 
S   be the quantity of basic research output measured by scientific publications; 
P   the quantity of applied research output measured by patents; 
G   the number of Ph.D. students trained; 
life E ,  engr E , phy E  R&D expenditures in the life sciences, engineering, and physical sciences 
respectively; 
nano E   R&D expenditures in nanotechnology awarded by federal agencies; 
RK   quality ranking of relevant science and engineering programs; 6 
 
 
Pubpriv  the public/private status of a university (1=public, 0=private); 
Land   the land-grant identity (1=landgrant, 0=non-land-grant); 
Hosp  the presence of a university hospital (1=with hospital, 0=without hospital); 
Med  the presence of a medical school (1=with medical school, 0=without medical 
school); 
CTR  presence of a multidisciplinary nanotechnology research center (1=with a 
center, 0=without a center); 
stock S   university knowledge stock, measured by the discounted accumulation of 
scientific publications from previous years; 
TTO  a vector of the university Technology Transfer Office’s (TTO) characteristics, 
including its operating budget, staff size, and previous patenting and licensing 
success; 
EDU   presence of a formal multidisciplinary nanotechnology education program 
(1=with a education program, 0=without an education program). 
  A university’s basic and applied nanobiotech research and graduate-training production 
functions can then be specified as: 
(1)    stock nano nano phy engr life S CTR Med Hosp Land Pubpriv E RK RK E E E E G P f S , , , , , , * , , , , , , ,   
(2)    TTO CTR Med Hosp Land Pubpriv E RK RK E E E E G S f P nano nano phy engr life , , , , , , * , , , , , , ,   
(3)   EDU CTR Med Hosp Land Pubpriv E RK RK E E E E S P f G nano nano phy engr life , , , , , , * , , , , , , ,   
where time subscripts and lag operators are, for notional simplicity, suppressed.  These three 
equations appear simultaneous.  Research and graduate training serve as inputs to one another:  7 
 
students assist with their professors’ research programs, and experience with a professor’s 
research in turn is an essential element in a student’s education.  At the same time, research and 
education compete for the professor’s time and other resources.  Model (1) – (3) allows for such 
interactions, so that synergies or tradeoffs among articles, patents, and graduate student training 
can be assessed. 
  Since resources are poorly allocable between research and graduate training, the same 
R&D expenditure variables are included in all three production equations.  In equation (1), 
derivative  nsfnano E S   /   reflects the marginal products of the NSF R&D investments in basic 
nanobiotech research, i.e., by how much an additional dollar of R&D investment increases 
scientific publications and elasticity associated with the derivatives indicate the returns of basic 
research to budget scale.  Marginal products of R&D investments and returns to budget scale — 
two measures of returns to R&D investments — in applied nanobiotech research and graduate 
training can be derived similarly from equations (2) and (3), respectively.   
University nanobiotech success depends on factors beyond the budget directly devoted to 
it.  First, a university’s research efforts in other fields such as the life sciences, engineering, and 
physical sciences may contribute to its nanobiotech program.  This contribution is represented by 
the partial derivatives of the left-hand-side output variables with respect to R&D expenditures in 
those fields.  Second, university research and education in nanobiotech likely are affected by 
prior conditions of its nanobiotech-related programs, which can be measured by relevant science 
and engineering program rankings.  Higher-ranked universities attract higher-quality professors 
and graduate students and hence can produce more output with a given budget.  Furthermore, 
higher program rankings can indirectly contribute to output by enhancing the research and 
education products of another dollar of R&D expenditure.  Such enhancements are found by 8 
 
differentiating the respective marginal products of R&D expenditures with respect to program 
ranking, which are represented by the coefficients of the cross terms between R&D expenditures 
and program rankings in model (1) - (3).  Third, a university’s public/private status and land-
grant identity may impact its orientation toward basic research, applied research, and student 
training.  Fourth, nanobiotech research is highly interdisciplinary.  The presence of a 
multidisciplinary nanotechnology research center would facilitate information flows, foster 
collaborative research relationships among faculty from different disciplines, and provide 
students with opportunities to gain hands-on experience in laboratories other than their major 
professors’.  Finally, three variables are employed in structural equations (1) - (3) as identifying 
variables, respectively indicative of (i) the university’s science base in nanobiotech upon which 
its faculties can further pursue their scientific inquiries, (ii) its technology transfer capacity, and 
(iii) its intensity in nanotechnology teaching.    
 
Data 
Research universities are sorted into three strata — land-grant universities, non-land-
grant public universities, and private universities.  Annual data are collected from a random 
sample of ten universities in each stratum that participated in nanobiotech from 1990 to 2005.  
The following broad sets of life-science keywords are constructed and used jointly with “nano” 
to search for data in nanobiotech field from various sources: 
nano$ and (bio$ or DNA or RNA or genetic$ or protein or patholog$ or bacteria$ or fungus or 
fungi or metaboli$ or enzyme or physiology$ or entomolog$ or ecolog$ or human or medic$ or 
cancer or blood or immunolog$ or pharmac$ or toxicolog$ or neuron$ or agricult$ or animal$ or 
livestock or aquatic$ or crop$ or veget$ or fruit$ or food$) 9 
 
 Using the above keyword set, I first draw scientific publications in nanobiotech authored 
by each university in each year from ISI’s Science Citation Index Expanded.  I then draw 
nanobiotech patents awarded to each university in each year from the U.S. Patent Office 
database.  Although a new patent class for nanotechnology was created in 2004, all previously 
issued patents belonging to this class may not have been re-classified to it.  Nanobiotech patents 
therefore have to be identified by applying the keyword set.  Data on graduate students trained in 
nanobiotech at each of the 30 sample universities are obtainable from Dissertation Abstract, a 
source covering graduate theses accepted at all accredited U.S. institutions.  The keyword set is 
employed to search for nanobiotech theses by year and university, indicating the numbers of 
Master’s and Ph.D. degrees awarded in this field.   
Federal agencies committing significant investments to nanobiotech include the National 
Institutes of Health (NIH), National Science Foundation (NSF), U.S. Department of Energy 
(DoE), U.S. Department of Defense (DoD), and U.S. Department of Agriculture (USDA).  In 
principle, search for life-science and nanotechnology keywords will filter out sponsored 
nanobiotech research projects in each agency’s award record database.  Each university’s 
nanobiotech R&D expenditures from the federal government can then be derived.  
Unfortunately, all federal agencies except NSF do not maintain award record databases that are 
searchable by keywords and hence, data on federal supports for a university’s R&D in 
nanotechnology can only include those from NSF.   Annual data on university R&D 
expenditures in the life sciences, engineering, and physical sciences are directly available from 
NSF’s WebCASPAR database.   
Data on graduate program ranking and other university fixed factors such as public-
private status, land-grant identity, and presence of university hospital and medical school are 10 
 
provided by the Gourman Report and the U.S. Department of Education.  Lists of 
nanotechnology research centers and educational programs sponsored by the federal government 
are available from NNI.  These are cross-checked and complemented by a search of each 
university’s website.  Information on institutional characteristics of university TTOs is available 
from the Association of University Technology Transfer Managers’ (AUTM) annual report.     
Descriptive statistics are presented in Table 1.  Data on research and education outputs of 
each university between 1990 and 2005 are provided in Table 2.  Annual breakdown of these 
outputs are reported in Table 3.  The thirty sample universities generated a total of 3088, 1507, 
and 705 publications, patents, and PhD degrees in nanobiotechnology respectively during the 
whole study period.  Very few Master’s degrees were awarded.  All the thirty universities’ 
publications together increased from 6 in 1990 to 723 in 2005.  During the same period, their 
patents grew from 28 to 162, while total number of PhD graduates jumped from 10 to 179. 
 
Results 
In the empirical estimation, a variety of temporal patterns in the basic research, applied 
research, and graduate education equations, including distributed lags as well as finite lags on 
individual factors, are examined.  The three equations (1)-(3) can be fitted alternately with OLS, 
SUR, a fixed-effects estimator, and a GLS model.  Single-equation estimates in table 4 have
2 R s 
respectively at 0.67, 0.49, and 0.61 for the three equations, rather high considering the wide 
variety of sample universities.   
NSF investment in nanobiotechnology significantly affects the university’s basic science 
research and graduate education, but the effects are small with sample-mean elasticities of 0.06% 
and 0.16%, respectively.  NSF funding has nonsignificant effect on the university’s patent 11 
 
numbers.  The university’s R&D expenditures in life sciences has a strong positive effect on it’s 
basic and applied research: a one-percent increase in life science R&D induces a 0.35% and 
1.18%  increases in university scientific publications and patents.  The university’s research 
expenditures in physical sciences and engineering respectively has a strong positive effect on it’s 
applied research and Ph.D. training.  Every one-percent increase in physical sciences and 
engineering R&D respectively leads to a 0.23% and 0.27% increase in patents and Ph.D. degrees 
awarded.   
Importantly, there is no evidence that research and graduate training compete strongly 
with one another.  Rather, basic science research and graduate education serve as strong 
complements to one another, basic science and applied research, and applied research and 
graduate education both serve as weak complements for one another.   
Ceteris paribus, non-land-grant public universities and universities without medical 
school or hospital are more efficient in patent production than their land-grant and private 
counterparts and those with medical school and hospital.  Such characteristics of universities, 
however, do not significantly affect the universities’ efficiencies in basic research and graduate 
education.  Presence of a nanotechnology research center on campus enhances the university’s 
basic science research and a formal nanotechnology education program promotes the university’s 
graduate education.   
 
Discussions 
As an enabling or platform technology, nanotechnology has extraordinary potential to 
enhance innovation, technical change, and productivity growth in a wide variety of industries, 
helping to maintain the competitiveness and sustainability of the U.S. economy.  12 
 
Nanobiotechnology is one of the most active and promising application frontiers in 
nanotechnology.   
Universities indeed serve as a principal seedbed for future development of the cutting-
edge nanobiotechnology.  Empirical results in the present study shed light on the productivity 
effects of public investment and policy choices in university nanobiotechnology research and 
education.  For example, the results indicate significant returns to federal investments in 
nanobiotech itself as well as the contributions of R&D expenditures devoted to related fields.  
They illustrate which types of university, public or private, land-grant or non-land-grant, with 
hospital and medical school or without, make more efficient uses of resources for basic research, 
applied research, and graduate student training.  They demonstrate that a nanotechnology 


























Table 1.  Descriptive Statistics 
 
Variable Max  Min  Mean  St.  Dev 
  
Publications 59  0  6.43  8.55 
Patents 28  0  3.14  4.14 
PhD degrees  22  0  1.47  2.30 
Eng. R&D (million $)  381.38  1.22  56.94  62.76 
Phy. sci. R&D (million $)  150.56  0  28.48  27.39 
Life sci. R&D (million $)  596.53  0.55  160.45  121.41 




































Table 2.  Publications, Patents, and Ph.D. Degrees Awarded in Nanobiotechnology: University 
Totals Between 1990 and 2005 
 
Institution Publications  Patents  PhD  degrees 
Case Western Reserve University  44  27  8 
Columbia University  70  58  18 
Cornell University  148  86  55 
Georgia Institute of Technology  88  23  17 
Harvard University  303  81  33 
Johns Hopkins University  121  152  30 
Kansas State University  21  9  3 
Louisiana Tech University  44  0  15 
North Carolina State University  56  63  19 
Northwestern University  191  38  38 
Ohio State University  104  30  22 
Pennsylvania State University  138  0  42 
Rice University  65  34  19 
Stanford University  133  77  36 
Tufts University  41  5  5 
University of California-Los Angeles  124  53  31 
University of Cincinnati  40  17  17 
University of Illinois at Urbana-
Champaign 172  42  51 
University of Kansas  36  8  13 
University of Maryland  159  39  16 
University of Michigan  176  149  47 
University of Missouri-Columbia  33  12  5 
University of New Mexico  18  12  2 
University of Pennsylvania  114  96  27 
University of Texas-Austin  98  97  21 
The University of Utah  64  69  12 
University of Virginia  77  37  24 
University of Washington  164  68  35 
University of Wisconsin-Madison  131  79  28 
Washington University  115  46  16 
  






Table 3.  Publications, Patents, and Ph.D. Degrees Awarded in Nanobiotechnology: Annual 
Totals for Thirty Universities 
 
Year Publications  Patents  PhD  degrees 
  
1990 6  28  10 
1991 74  25  11 
1992 62  43  10 
1993 69  31  21 
1994 57  37  6 
1995 97  47  23 
1996 90  58  22 
1997 102  93  21 
1998 146  118  40 
1999 169  137  33 
2000 175  119  33 
2001 197  114  48 
2002 266  151  54 
2003 360  150  85 
2004 495  194  109 
2005 723  162  179 
  





















Table 4.  University Production of Publications, Patents, and Ph.D. Degrees in 
Nanobiotechnology: Parameter Estimates 
 
          Publications          Patents          PhD degrees 
Variable Estimate  t  Estimate  t  Estimate  t 
        
Intercept -2.304  -1.92  -0.583  -0.81  -1.584  -3.02 
Publications     0.055  1.98  0.153  13.32 
Patents 0.145  1.93      0.032  1.45 
PhD degrees awarded  1.759  13.61  0.198  2.11 
Eng. R&D  0.000  0.02  0.002  0.38  0.007  3.38 
Phy. sci. R&D  -0.003  0.21  0.025  2.66  -0.006  -1.33 
Life sci. R&D  0.014  3.41  0.023  8.26  -0.001  -0.92 
Nano R&D  0.136  2.54  0.006  0.15  0.086  5.33 
Pubpriv -0.249  -0.30  1.535  3.13  0.439  1.69 
Land grant  -0.243  -0.35  -1.858  -4.51  -0.134  -0.64 
Hospital -1.125  -1.74  -0.927  -2.38  0.073  0.37 
Med School  -0.188  -0.19  -1.100  -1.88  0.956  2.14 
Nano center  1.389  2.37  -0.692  -1.96  0.308  1.72 
Time trend  0.451  6.89  0.099  2.44  0.049  2.48 
Nano ed. program        0.874  2.54 
        
R
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